(Q38210280)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809909%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

title

G-protein-coupled receptor heteromers as key players in the molecular architecture of the central nervous system (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809909%20AND%20SRC:MED&resulttype=core&format=json

G protein-coupled receptor

17 March 2020

main subject

0 references

author

Marc Brugarolas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809909%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Eva Martínez-Pinilla

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809909%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Vicent Casadó

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809909%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

José L. Lanciego

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809909%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Rafael Franco

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809909%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

2

Gemma Navarro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809909%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

author name string

Edgar Angelats

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809909%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

publication date

9 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809909%20AND%20SRC:MED&resulttype=core&format=json

CNS Neuroscience & Therapeutics

17 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809909%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809909%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809909%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

page(s)

703-709

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809909%20AND%20SRC:MED&resulttype=core&format=json

G-protein-coupled receptor oligomerization and its potential for drug discovery

17 March 2020

cites work

1 reference

Functional and structural complexity of signal transduction via G-protein-coupled receptors

21 January 2018

1 reference

G-protein-coupled receptors and signaling networks: emerging paradigms.

21 January 2018

1 reference

On the expanding terminology in the GPCR field: the meaning of receptor mosaics and receptor heteromers.

21 January 2018

1 reference

Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons.

21 January 2018

1 reference

Oligomerization of G-protein-coupled transmitter receptors.

21 January 2018

1 reference

Detection of heteromerization of more than two proteins by sequential BRET-FRET.

21 January 2018

1 reference

Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking

21 January 2018

1 reference

Oligomerization of G-protein-coupled receptors: a reality

21 January 2018

1 reference

G protein-coupled receptor heteromers as new targets for drug development

21 January 2018

1 reference

Building a new conceptual framework for receptor heteromers

21 January 2018

1 reference

Heterodimerization of g protein-coupled receptors: specificity and functional significance.

21 January 2018

1 reference

History and biological significance of GPCR heteromerization in the neuroendocrine system

21 January 2018

1 reference

Hetero-oligomerization between beta2- and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties

21 January 2018

1 reference

Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation

21 January 2018

1 reference

Heterodimerization of mu- and delta-opioid receptors occurs at the cell surface only and requires receptor-G protein interactions.

21 January 2018

1 reference

Functional relevance of neurotransmitter receptor heteromers in the central nervous system.

21 January 2018

1 reference

Novel pharmacological targets based on receptor heteromers

21 January 2018

1 reference

Roles of G-protein-coupled receptor dimerization

21 January 2018

1 reference

The state of GPCR research in 2004.

21 January 2018

1 reference

Receptor activity-independent recruitment of betaarrestin2 reveals specific signalling modes

21 January 2018

1 reference

Role of endogenous cannabinoids in synaptic signaling

21 January 2018

1 reference

Cannabinoid receptors: where they are and what they do.

21 January 2018

1 reference

Endocannabinoid system and mood disorders: priming a target for new therapies

21 January 2018

1 reference

Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus

21 January 2018

1 reference

Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain

21 January 2018

1 reference

Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis

21 January 2018

1 reference

Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum

21 January 2018

1 reference

Physiology and pharmacology of striatal neurons

21 January 2018

1 reference

Adenosine A2A receptors and basal ganglia physiology

21 January 2018

1 reference

A2A receptor and striatal cellular functions: regulation of gene expression, currents, and synaptic transmission

21 January 2018

1 reference

Distribution, biochemistry and function of striatal adenosine A2A receptors

21 January 2018

1 reference

The role of the basal ganglia in habit formation

21 January 2018

1 reference

The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease

21 January 2018

1 reference

Past, present, and future of the pathophysiological model of the Basal Ganglia

21 January 2018

1 reference

L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: biochemical and behavioral studies

21 January 2018

1 reference

Interaction between adenosine A1 and A2 receptor-mediated responses in the rat hippocampus in vitro

21 January 2018

1 reference

Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers

21 January 2018

1 reference

A1R-A2AR heteromers coupled to Gs and G i/0 proteins modulate GABA transport into astrocytes.

21 January 2018

1 reference

Adenosine-cannabinoid receptor interactions. Implications for striatal function

21 January 2018

1 reference

Adenosine A(2A)-cannabinoid CB(1) receptor interaction: an integrative mechanism in striatal glutamatergic neurotransmission

21 January 2018

1 reference

Pre-synaptic adenosine A2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission.

21 January 2018

1 reference

Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids

21 January 2018

1 reference

Neurotransmitter receptor heteromers and their integrative role in 'local modules': the striatal spine module.

21 January 2018

1 reference

Heterodimeric adenosine receptors: a device to regulate neurotransmitter release.

21 January 2018

1 reference

Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors

21 January 2018

1 reference

Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells

21 January 2018

1 reference

Interactions between intracellular domains as key determinants of the quaternary structure and function of receptor heteromers

21 January 2018

1 reference

Detection of heteromers formed by cannabinoid CB1, dopamine D2, and adenosine A2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer.

21 January 2018

1 reference

Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes

21 January 2018

1 reference

Striatal pre- and postsynaptic profile of adenosine A(2A) receptor antagonists

21 January 2018

1 reference

Istradefylline, an adenosine A₂A receptor antagonist, for patients with Parkinson's Disease: a meta-analysis

21 January 2018

1 reference

Istradefylline for the treatment of Parkinson's disease

21 January 2018

1 reference

Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function.

21 January 2018

1 reference

The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors

21 January 2018

1 reference

Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats

21 January 2018

1 reference

Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian mice

21 January 2018

1 reference

Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia

21 January 2018

1 reference

Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson's disease

21 January 2018

1 reference

Adenosine A2A receptors enable the synaptic effects of cannabinoid CB1 receptors in the rodent striatum.

21 January 2018

1 reference

Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC.

21 January 2018

1 reference

Adenosine A2a blockade prevents synergy between mu-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats

21 January 2018

1 reference

Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons

21 January 2018

1 reference

Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth

21 January 2018

1 reference

Dopamine receptor homooligomers and heterooligomers in schizophrenia

21 January 2018

1 reference

Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes

21 January 2018

1 reference

Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors

21 January 2018

1 reference

Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists

21 January 2018

1 reference

Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function

21 January 2018

1 reference

Identification of a serotonin/glutamate receptor complex implicated in psychosis

21 January 2018

1 reference

Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs.

21 January 2018

1 reference

Regulation of heptaspanning-membrane-receptor function by dimerization and clustering

21 January 2018

1 reference

12 December 2020

Does the absence of clinical expression of choreoathetosis, despite severe striatal atrophy, correlate with plasticity of neuropeptide synthesis?

1 reference

12 December 2020

L-DOPA-treatment in primates disrupts the expression of A(2A) adenosine-CB(1) cannabinoid-D(2) dopamine receptor heteromers in the caudate nucleus.

1 reference

12 December 2020

Dopaminergic involvement in hypothalamic function: extrahypothalamic and hypothalamic control. A neuroanatomical analysis

1 reference

12 December 2020

Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system

1 reference

12 December 2020

Identifiers

DOI

10.1111/CNS.12277

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809909%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809909%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

PubMed publication ID

24809909

1 reference